drugset / Trial / NCT04386811

Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD: a Proof-of-concept Tele-health Study of Stimulant-induced Improvement in Neurocognitive Functioning.

NCT04386811

Phase 1 Terminated 3 enrolled Yale University
RandomizedCrossoverSingle-blindTreatment

Summary

The purpose of this study is to assess vitamin D as a therapeutic adjunct in the stimulant treatment of ADHD.

Timeline

Start
2020-08-05
Primary completion
2020-09-29
Completion
2020-09-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcitriol Small molecule